Professor, Department of Obstetrics and Gynaecology ; Deputy Director, Prenatal Genetic Diagnosis Centre, CUHK; Director, Pre-implantation Genetic Diagnosis Laboratory, CUHK
BIOGRAPHY
Date & Time
Date: April 22, 2021
Time: 10:00am (CEST), 4:00pm (CST)
Abstract
Advancements in technologies have revolutionized the genetic landscape. Chromosomal microarray analysis (CMA) becomes a proven method and is implemented to detect gains and losses of DNA and absence of heterozygosity across the genome. Next-generation sequencing technologies have brought opportunities and challenges to genetic testing, its prenatal application is an emerging field. We describe our experience using FetalChip, a CMA for prenatal research developed in our laboratory and describe the role of CMA in the era of genome sequencing.
Learning Objectives
- The role of chromosomal microarray analysis (CMA) in prenatal genetic clinical research.
- CMA is a well-established and proven technology to identify pathogenic CNVs
- The utility of genome sequencing
For Research Use Only. Not for use in diagnostic procedures.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
JAN 14, 2026 | 10:00 AM
Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge and accurate, timely diagnosis is cri...
JAN 15, 2026 | 8:00 AM
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...
JAN 20, 2026 | 11:00 AM
CAR-T translational research demands precise, reproducible, and scalable flow cytometry workflows. Manual centrifugation and antibody preparation steps remain major sources of variability an...
JAN 20, 2026 | 9:15 AM
Bloodstream infections (BSIs) remain a critical challenge in clinical care, where every hour of delay in diagnosis can significantly impact patient outcomes. This webinar explores findings f...
JAN 21, 2026 | 8:45 AM
C.E. CREDITS
Lipid nanoparticles (LNPs) have become the gold standard in non-viral gene delivery technologies, exemplified by the approval of the LNP messenger RNA (mRNA) vaccines against SARS-CoV-2. Sin...
JAN 22, 2026 | 8:00 AM
Cell line development (CLD) is often a critical bottleneck in biopharmaceutical production, often requiring labor-intensive workflows and multiple sequential screening steps that extend time...
Loading Comments...